Press Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
May 4, 2015Traverse Biosciences Also Grants Aratana Therapeutics the Exclusive Option to Sublicense TRB-N0224
Traverse Biosciences announced today that it has executed a $250,000 cooperative research and development agreement (CRADA) with Aratana Therapeutics Inc. (NASDAQ: PETX) to advance the development...
-
May 1, 2015Conference Call and Webcast scheduled for May 8, 2015, 8:30 a.m. ET
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals,...
-
Apr 27, 2015ADXS31-164 (AT-014) in Combination with Palliative Radiation Delays Tumor Progression, Prolongs Overall Survival and Maintains Limb Function in Preliminary Data from a Clinical Study in Canine Osteosarcoma
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals,...
-
Apr 22, 2015
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals,...
-
Mar 19, 2015
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals,...
-
Mar 12, 2015-- Provides additional product updates --
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals, announced...
-
Mar 11, 2015Conference Call and Webcast scheduled for March 13, 2015, 8:30 a.m. ET
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals,...
-
Mar 4, 2015
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals,...
-
Feb 24, 2015Product is the first approved monoclonal antibody to aid in the treatment of canine B-cell lymphoma
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals,...
-
Feb 10, 2015Provides additional details on AT-001 pivotal efficacy study, announces two technical section complete letters for safety, provides manufacturing update for AT-004, and announces completion of enrollment for AT-005's T-CHOMP study
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals,...
-
Feb 6, 2015
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals,...
-
Jan 19, 2015
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals,...
-
Jan 5, 2015Represents a Novel Approach to Treating B-cell Lymphoma in Dogs
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals,...
-
Dec 18, 2014
Aratana Therapeutics, Inc. (NASDAQ: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for companion animals, today announced...
-
Dec 16, 2014Product is being developed to treat post-surgical pain in dogs
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals,...
-
Dec 5, 2014
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and commercialization of innovative biopharmaceutical products for cats,...
-
Nov 28, 2014
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and commercialization of innovative biopharmaceutical products for cats,...
-
Nov 17, 2014
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and commercialization of innovative biopharmaceutical products for cats,...
-
Nov 10, 2014- Conference Call Tomorrow, November 11, 2014, 8:30 a.m. Eastern Time -
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals, today...
-
Nov 4, 2014Conference Call and Webcast scheduled for November 11, 2014, 8:30 a.m. ET
Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals, will host a...
-
Oct 13, 2014Aratana to Develop CRTH2 Antagonist for Atopic Dermatitis in Companion Animals
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals, and Atopix...
-
Oct 10, 2014Investigators' Oral and Poster Presentations Highlight Canine Lymphoma Antibody Programs
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals, today...
-
Sep 18, 2014
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals, today...
-
Sep 17, 2014
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals, today...
-
Sep 16, 2014
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals, today...
-
Sep 9, 2014AT-003 Demonstrates Greater Pain Control Over Time Compared to Placebo in Client-Owned Dogs
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals, today...
-
Sep 5, 2014
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals, today...
-
Aug 12, 2014--Conference Call Today, August 12, 2014, 8:30 a.m. Eastern Time--
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals, today...
-
Aug 7, 2014
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for cats, dogs and other companion...
-
Aug 7, 2014Conference Call and Webcast scheduled for Tuesday August 12, 2014, 8:30 a.m. ET
Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for cats, dogs and other companion...
-
Jul 2, 2014
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for cats, dogs and other companion...
-
Jun 23, 2014
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for cats, dogs and other...
-
Jun 19, 2014
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for cats, dogs and other companion...
-
Jun 18, 2014
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for cats, dogs and other companion...
-
Jun 12, 2014Enters Exclusive License Agreement with Vet-Stem, Inc. for Allogeneic Stem Cell Technology
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for cats, dogs and other companion...
-
Jun 9, 2014Data Presented from Company's Pain, Cancer Immunotherapy, and Inappetence Programs
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for cats, dogs and other companion...
-
May 30, 2014
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for cats, dogs and other companion...
-
May 23, 2014
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for cats, dogs and other companion...
-
May 13, 2014--Conference Call Today, May 13, 2014, 4:45 p.m. Eastern Time--
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for cats, dogs and other companion...
-
May 12, 2014Product is being developed to treat pain in dogs with osteoarthritis
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for cats, dogs and other...
-
May 5, 2014Conference Call and Webcast scheduled for May 13, 2014, 4:45 p.m. ET
Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for cats, dogs and other...
-
May 2, 2014
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for cats, dogs and other...
-
Mar 27, 2014Sets Date and Location for 2014 Annual Meeting of Stockholders
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for cats, dogs and other...
-
Mar 19, 2014-- Collaboration Focused on Cancer Immunotherapies for Pets --
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for cats, dogs and other...
-
Mar 13, 2014-- Conference Call Today, March 13, 2014, 8 a.m. Eastern Time --
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for cats, dogs and other companion...
-
Mar 11, 2014Conference Call and Webcast scheduled for March 13, 2014, 8:00 a.m. ET
Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the licensing or acquisition, development and commercialization of innovative biopharmaceutical products for cats,...
-
Mar 6, 2014
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and commercialization of innovative biopharmaceutical products for cats,...
-
Feb 5, 2014
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and commercialization of innovative biopharmaceutical products for cats,...
-
Jan 29, 2014
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and commercialization of innovative biopharmaceutical products for cats,...
-
Jan 29, 2014
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and commercialization...
-
Jan 28, 2014AT-005 Marks Aratana's First Commercial Opportunity in T-cell Canine Lymphoma
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and commercialization of innovative biopharmaceutical products for cats,...
-
Jan 22, 2014
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and commercialization...
-
Jan 6, 2014Adds to European presence and expands product portfolio
Aratana Therapeutics, Inc. (NASDAQ: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, today announced that it has...
-
Dec 23, 2013Achieves All Year-End Clinical Milestones
Aratana Therapeutics, Inc., (Nasdaq: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, today provided a year-end...
-
Dec 11, 2013
Aratana Therapeutics (NASDAQ: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, today announced that it will...
-
Nov 20, 2013
Aratana Therapeutics, Inc. (NASDAQ: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, today announced positive...
-
Nov 19, 2013
Aratana Therapeutics, Inc. (NASDAQ: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, today announced that it will...
-
Nov 13, 2013Conference Call tomorrow Thursday, November 14, 2013, at 8 a.m. Eastern Time
Aratana Therapeutics, Inc. (NASDAQ: PETX) today announced its third quarter 2013 financial results and recapped its development activities.
-
Nov 11, 2013Craig Tooman Appointed Chief Financial Officer
Aratana Therapeutics, Inc. (NASDAQ: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, today announced that it has...
-
Nov 5, 2013Conference Call and Webcast scheduled for November 14, 2013, 8:00 a.m. ET
Aratana Therapeutics, Inc. (Nasdaq: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, will host a conference call...
-
Oct 24, 2013John Paolucci Joins Aratana as Director of Marketing
Aratana Therapeutics (NASDAQ: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, today announced that it has...
-
Oct 21, 2013
Aratana Therapeutics, Inc. (Nasdaq: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, today announced that it has...
-
Oct 15, 2013The Mayor's Alliance for NYC's Animals and Adoptable Pets to Join Aratana on NASDAQ Stage
Aratana Therapeutics (Nasdaq: PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets (pet...
-
Oct 14, 2013Adds Biologics to its Pet Therapeutics Platform
Aratana Therapeutics, Inc. (Nasdaq: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of...
-
Oct 1, 2013
Aratana Therapeutics (Nasdaq: PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets (pet...
-
Sep 27, 2013Presentation Scheduled for Friday, September 27 at 10:30 a.m. ET
Aratana Therapeutics (Nasdaq: PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative prescription medications for pets (pet...
-
Sep 5, 2013
Aratana Therapeutics (Nasdaq: PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative prescription medications for pets (pet...
-
Sep 3, 2013Presentation and Award Sponsorship Showcase Aratana's Vision and Pursuit of Innovation
Aratana Therapeutics (Nasdaq: PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets (pet...
-
Aug 29, 2013To Be Held September 11, 2013, 6:00 p.m. Eastern Time
Aratana Therapeutics (Nasdaq: PETX), a development-stage biopharmaceutical company focused on the licensing, development and...
-
Aug 12, 2013Announces Expansion of Pet Therapeutics Pipeline
Aratana Therapeutics, Inc. (NASDAQ: PETX) today announced its financial results for the second quarter of 2013, product development...
-
Jul 23, 2013Conference Call and Webcast scheduled for August 13, 2013, 8:00 a.m. ET
Aratana Therapeutics, Inc. (NASDAQ: PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative prescription medications for...
-
Jul 11, 2013
Aratana Therapeutics, Inc. (NASDAQ: PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative prescription medications for...
-
Jun 27, 2013
Aratana Therapeutics, Inc., a development-stage biopharmaceutical company focused on the licensing, development and commercialization...
-
Mar 26, 2013Marie-Paul Lachaud, D.V.M., to Expand European Operations
Aratana Therapeutics, Inc., a biopharmaceutical company focused on licensing, developing and commercializing innovative prescription...
-
Mar 20, 2013
Aratana Therapeutics, Inc., a biopharmaceutical company focused on licensing, developing and commercializing innovative prescription...
-
Mar 7, 2013
Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today announced...
-
Feb 12, 2013
Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today...
-
Jan 31, 2013
Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today announced...
-
Jan 24, 2013
Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today announced the appointment of Erick Lucera as Vice President of...
-
Jan 15, 2013
Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today announced it has appointed an experienced animal health executive...
-
Jan 2, 2013
Aratana Therapeutics, an animal health company developing innovative medicines for cats and dogs (companion animals), announced today that president and CEO Steven St. Peter, M.D. will be...
-
Dec 5, 2012
PARSIPPANY, N.J. and KANSAS CITY, Kan., December 6, 2012 – Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) and Aratana Therapeutics Inc. today announced a global licensing agreement for the...
-
Oct 23, 2012
Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today...
-
Oct 4, 2012
Aratana Therapeutics, an animal health company developing innovative medicines for cats and dogs (companion animals), today announced...
-
Sep 27, 2012
Aratana Therapeutics, an animal health company developing innovative medicines for cats and dogs (companion animals), today announced...
-
Sep 12, 2012
Aratana Therapeutics, an animal health company developing innovative medicines for companion animals, today announced that Company...